These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37945150)

  • 1. Hepatocellular Carcinoma.
    Yopp AC; Majella Doyle MB
    Surg Oncol Clin N Am; 2024 Jan; 33(1):xv-xvi. PubMed ID: 37945150
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of Kin17 promotes the proliferation of hepatocellular carcinoma cells
    Kou WZ; Xu SL; Wang Y; Wang LW; Wang L; Chai XY; Hua QL
    Oncol Lett; 2014 Sep; 8(3):1190-1194. PubMed ID: 25120685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma.
    Nie X; Liu Y; Chen WD; Wang YD
    Front Pharmacol; 2018; 9():657. PubMed ID: 29977206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal microRNAs in hepatocellular carcinoma.
    Liu C; Wu H; Mao Y; Chen W; Chen S
    Cancer Cell Int; 2021 May; 21(1):254. PubMed ID: 33964930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular carcinoma surveillance].
    Costentin C
    Presse Med; 2017 Apr; 46(4):381-385. PubMed ID: 28081946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma.
    Huang X; Wang M; Zhang D; Zhang C; Liu P
    J Hepatocell Carcinoma; 2024; 11():113-129. PubMed ID: 38250308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current staging of hepatocellular carcinoma: imaging implications.
    Bhosale P; Szklaruk J; Silverman PM
    Cancer Imaging; 2006 Jul; 6(1):83-94. PubMed ID: 16829469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDC6 is a possible biomarker for hepatocellular carcinoma.
    Kong DG; Yao FZ
    Int J Clin Exp Pathol; 2021; 14(7):811-818. PubMed ID: 34367412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma.
    Liu W; Zhong C; Lv D; Tang M; Xie F
    Front Genet; 2020; 11():863. PubMed ID: 32903675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular formation surrounding hepatocellular carcinoma.
    Iwamura K
    Tokai J Exp Clin Med; 1986 Aug; 11(3):185-99. PubMed ID: 3039694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between microRNA-21 and expression of Th17 and Treg cells in microenvironment of rats with hepatocellular carcinoma.
    Yao SX; Zhang GS; Cao HX; Song G; Li ZT; Zhang WT
    Asian Pac J Trop Med; 2015 Sep; 8(9):762-5. PubMed ID: 26433664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and hepatocellular carcinoma: correlated or uncorrelated?
    Wu XZ; Chen D
    J Gastroenterol Hepatol; 2006 Feb; 21(2):345-7. PubMed ID: 16509857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1, MUC2 and MUC5AC expression in hepatocellular carcinoma with cardiac metastasis.
    Lin YS; Jung SM; Yeh CN; Chen YC; Tsai FC; Shiu TF; Wu HH; Lin PJ; Chu PH
    Mol Med Rep; 2009; 2(2):291-4. PubMed ID: 21475827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-205 is downregulated in hepatocellular carcinoma and inhibits cell growth and metastasis via directly targeting vascular endothelial growth factor A.
    Zhao X; Zhou S; Wang D; He W; Li J; Zhang S
    Oncol Lett; 2018 Aug; 16(2):2207-2214. PubMed ID: 30008920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RUNX3 Promoter Methylation Is Associated with Hepatocellular Carcinoma Risk: A Meta-Analysis.
    Zhang X; He H; Zhang X; Guo W; Wang Y
    Cancer Invest; 2015 Apr; 33(4):121-5. PubMed ID: 25664646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2.
    Cen W; Li J; Tong C; Zhang W; Zhao Y; Lu B; Yu J
    J Cancer; 2021; 12(12):3448-3457. PubMed ID: 33995623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift.
    Tan CK; Chow PK; Findlay M; Wong C; Machin D
    J Gastroenterol Hepatol; 2000 Jul; 15(7):725-9. PubMed ID: 10937676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Presentation of Hepatocellular Carcinoma in a Young Adult: A Case Report.
    Elmakki EE
    Oman Med J; 2014 Jan; 29(1):e065. PubMed ID: 30834065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma.
    Zhou H; Su L; Liu C; Li B; Li H; Xie Y; Sun D
    Onco Targets Ther; 2019; 12():7823-7831. PubMed ID: 31576140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma.
    Cheng CC; Liu YH; Ho CC; Chao WT; Pei RJ; Hsu YH; Yeh KT; Ho LC; Tsai MC; Lai YS
    J Mol Histol; 2008 Apr; 39(2):209-16. PubMed ID: 18038249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.